openPR Logo
Press release

Autologous Matrix-Induced Chondrogenesis Market to Grow with Increasing Prevalence of Joint Disorders

05-19-2023 11:49 AM CET | Health & Medicine

Press release from: Persistence Market Research

Autologous Matrix-Induced Chondrogenesis Market to Grow with

It is a biological procedure used in the Autologous Matrix-Induced Chondrogenesis (AMIC) Market to treat damaged articular cartilage. AMIC therapy is carried out in stages. After microfracture surgery, a bi-layer collagen I/III membrane is applied. With the goal of avoiding or delaying partial or total surgery for minor joint replacement (such as a knee replacement), it slows down cartilage deterioration. Chondral lesions in Grade III or IV, ranging in size from 2 cm2 to 8 cm2, are among the indications for AMIC.

Request for Free Sample Copy@ https://www.persistencemarketresearch.com/samples/12271

In terms of value, the global autologous matrix-induced chondrogenesis (AMIC) Market is anticipated to grow at a CAGR of 8.6% during the forecast period. The value of the global market for autologous matrix-induced chondrogenesis is projected to be US$ 96.11 Million in 2016 and US$ 186.4 Million by the end of 2024.

The need for minimally invasive procedures has greatly increased in recent years. Patients are being encouraged to choose minimally invasive surgeries by benefits such less post-surgery complications and side effects, quicker patient recovery, and shorter hospital stays. As a result, the market for autologous matrix-induced chondrogenesis is anticipated to grow over the course of the forecast period due to the increased need for minimally invasive operations.

Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/12271

Most of the countries have less or no reimbursement for autologous matrix-induced chondrogenesis products or procedures. Autologous matrix-induced chondrogenesis products or procedures are not reimbursed by several health insurance companies in Europe. There is no reimbursement in most of the developing countries such as India, Australia, and Brazil. Hence, lack of efficient reimbursement is likely to hamper the growth of the autologous matrix-induced chondrogenesis market during the forecast period.

Regional analysis : Autologous Matrix-induced Chondrogenesis Market

The global Autologous Matrix-Induced Chondrogenesis market has been segmented into five major regions: North America, Latin America, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA).

In terms of value, North America is estimated to be the dominant market for global Autologous Matrix-Induced Chondrogenesis market in 2016 and expected to witness a CAGR of 8.3% over the forecast period. APAC is estimated to be the fastest growing markets in terms of CAGR. PEG segment in the North America Autologous Matrix-Induced Chondrogenesis market is expected to register a CAGR of 11.3% over the forecast period.

Request For Customization @ https://www.persistencemarketresearch.com/request-customization/12271

Market Segmentation : Autologous Matrix-induced Chondrogenesis Market

• Autologous Matrix-induced Chondrogenesis Market By Material : Hyaluronic, Acid, Collagen, Polyethylene glycol (PEG), polylactic-co-glycolic acid (PGLA), Others
• Autologous Matrix-induced Chondrogenesis Market By Region : North America, Latin America, Europe, Asia pacific, MEA

Key market players

• Anika Therapeutics, Inc.,
• Arthro-Kinetics,
• Braun Melsungen AG,
• BioTissue AG,
• CartiHeal,
• Geistlich Pharma AG,
• JRI Orthopaedics Ltd.,
• Matricel GmbH,
• Smith & Nephew plc,
• Zimmer Biomet Holdings.

Some other Trending Reports -

Pressure Guidewires Market - https://www.persistencemarketresearch.com/market-research/pressure-guidewires-market.asp

Intra Operative Imaging Market - https://www.persistencemarketresearch.com/market-research/intra-operative-imaging-market.asp

About us:
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Autologous Matrix-Induced Chondrogenesis Market to Grow with Increasing Prevalence of Joint Disorders here

News-ID: 3059665 • Views:

More Releases from Persistence Market Research

North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and
Global Forged Automotive Components Market Poised for Steady Growth, Projected to Reach US$ 70.7 Billion by 2032
Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts. Forged automotive components are critical to
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ 2.14 Billion by 2032, Reports Persistence Market Research
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Driven by Urbanization and Demographic Trends
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring

All 5 Releases


More Releases for Autologous

Transformative Trends Impacting the Autologous Cell Therapy Market Landscape: Te …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Autologous Cell Therapy Market Size By 2025? The market size for autologous cell therapy has seen a swift expansion in the past few years. The growth is projected to increase from $10.28 billion in 2024 to $12.19 billion in 2025, at a compound annual growth
Emerging Trends Influencing The Growth Of The Autologous Cell Therapy Market:Tec …
The Autologous Cell Therapy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Autologous Cell Therapy Market Size Expected to Be by 2034? The Autologous Cell Therapy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from
Prominent Autologous Stem Cell And Non-Stem Cell Based Therapies Market Trend fo …
What Are the Projected Growth and Market Size Trends for the Autologous Stem Cell And Non-Stem Cell Based Therapies Market? The market size for autologous stem cell and non-stem cell based treatments has experienced rapid expansion in recent years. In numerical terms, it is predicted to rise from $9.96 billion in 2024 to $11.59 billion in 2025, with a compound annual growth rate (CAGR) of 16.5%. The significant growth during the
Autologous Cell Therapy Market Growth Outlook 2027
Transparency Market Research (TMR) has published a new report titled, 'Autologous cell therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global autologous cell therapy market was valued at US$ 7.5 Bn in 2018 and is projected to expand at a CAGR of 18.1% from 2019 to 2027. Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=715 Overview • Cell therapy also termed as cellular therapy
Autologous Cell Therapy Market Insights Shared in Detailed Report
Transparency Market Research (TMR) has published a new report titled, 'Autologous cell therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global autologous cell therapy market was valued at US$ 7.5 Bn in 2018 and is projected to expand at a CAGR of 18.1% from 2019 to 2027. Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=715 Overview • Cell therapy also termed as cellular therapy
Autologous Cell Therapy Market: High Prevalence of Cancer Triggers Demand for Au …
Global Autologous Cell Therapy Market: Overview Autologous cell therapy refers to infusion or transfer of human tissue or cells back to the same person for treating a diseased part. For the same purpose, stem cells are removed from the patient, harvested, cultured, and once again transplanted to the same person. The purpose of this method is to reduce the chances of rejection to the treatment by the body. Furthermore, autologous cell